Compound C108 - ≥98% , CAS No.15533-09-2

CAS: 15533-09-2 Cat. No.: C649291 Formula: C15H14N2O3 Peso molecolare: 270.28 Numero EC: 111-040-4 PubChem CID: 135472588
Disponibile su ordine
QUALITÀ & PUREZZA ≥98%
Storage
Protected from light,Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
5mg
C649291-5mg
Su ordinazione · 8–12 settimane

127,47€

191,68€
Salva 64,21 € (33.50%)
10mg
C649291-10mg
Su ordinazione · 8–12 settimane

229,00€

343,54€
Salva 114,54 € (33.34%)
25mg
C649291-25mg
Su ordinazione · 8–12 settimane

499,73€

749,64€
Salva 249,91 € (33.34%)
50mg
C649291-50mg
Su ordinazione · 8–12 settimane

849,43€

1.274,62€
Salva 425,19 € (33.36%)
100mg
C649291-100mg
Su ordinazione · 8–12 settimane

1.443,83€

2.165,79€
Salva 721,96 € (33.33%)
Enter a quantity for the sizes you want to add.

Panoramica

Compound C108 is a G3BP2 inhibitor. Compound C108 also targeted stress granule-associated proteins and Gtpase-activating protein (SH3 domain) binding protein 2. Compound C108 potently inhibits esophageal squamous cell carcinoma (ESCC) cell metastasis

In Vitro

Compound C108 (1 μM; 24 h) shows anti-tumor activity against BT474 cells. Compound C108 (4 μM; 24 h) significantly decreases the protein expression of G3BP2 in G3BP2 overexpressing KYSE410 cells and LINC01554 transfected KYSE30 cells. Compound C108 (4 μM; 24 h) attenuates ESCC cell metastasis, migration and invasion in KYSE410, KYSE30 and KYSE150 cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: G3BP2-overexpressing KYSE410 cells, LINC01554-transfected KYSE30 cells Concentration: 4 μM Incubation Time: 24 h Result: Decreased the protein level of G3BP2 and HDGF.

In Vivo

Compound C108 (1 μM; 24 h) targets and decreases tumor initiating cells (TICs), while injected BT-474 cells treated with Compound C108 into the mammary fat pad of female nonobese diabetic/severe combined immune deficiency (NOD-SCID) mice in a limiting-dilution xenograft assay . MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Form:Solid

IC50& Target:G3BP2

Specifiche

Specifiche e purezza
≥98%
Meccanismi biochimici e fisiologici
Compound C108 is a G3BP2 inhibitor. Compound C108 also targeted stress granule-associated proteins and Gtpase-activating protein (SH3 domain) binding protein 2. Compound C108 potently inhibits esophageal squamous cell carcinoma (ESCC) cell metastasis
Condizioni di conservazione di stoccaggio
Protected from light,Store at -80°C
Spedito in
Dry ice packs + Cold packs
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Tipo di azione
INHIBITOR
Purezza
≥98%
Nomi e identificatori
Sorrisi canonici
CC(=NNC(=O)C1=CC=CC=C1O)C2=CC=CC=C2O
IUPAC Name
2-hydroxy-N-[(E)-1-(2-hydroxyphenyl)ethylideneamino]benzamide
InChIKey
LQGMBUGEAAGJKW-MHWRWJLKSA-N
INCHI
1S/C15H14N2O3/c1-10(11-6-2-4-8-13(11)18)16-17-15(20)12-7-3-5-9-14(12)19/h2-9,18-19H,1H3,(H,17,20)/b16-10+
PubChem CID
135472588
Peso molecolare
270.28

Dati avanzati

Struttura 3D
Modello di struttura chimica interattiva





Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Proprietà chimiche e fisiche
SolubilitàDMSO : 25 mg/mL (92.50 mM; Need ultrasonic)
Peso molecolare270.280 g/mol
XLogP32.900
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count3
Exact Mass270.1 Da
Monoisotopic Mass270.1 Da
Topological Polar Surface Area81.900 Ų
Heavy Atom Count20
Formal Charge0
Complexity370.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds1
Covalently-Bonded Unit Count1
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.